From September 6, 2022 to September 30, 2022, the company has repurchased 1,789,485 shares, representing 1.94% for CNY 99.47 million. With this, the company has completed the repurchase of 1,789,485 shares, representing 1.94% for CNY 99.47 million under the buyback announced on September 6, 2022.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 CNY | -0.69% |
|
-2.83% | -37.30% |
1st Jan change | Capi. | |
---|---|---|
-37.30% | 308M | |
-7.03% | 178B | |
-6.32% | 98.95B | |
-6.15% | 66.14B | |
-10.62% | 44.11B | |
+8.34% | 43.82B | |
+11.91% | 42.07B | |
+11.64% | 28.92B | |
+17.68% | 24.69B | |
-8.87% | 23.38B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.